Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (27)
Jonathan L. Robbins, Kathryn Bonuck, Philippe Thuillier, Catriona Buist & Patricia A. Carney. (2022) Differences in perceived clinical knowledge uptake among health profession students and licensed clinicians receiving buprenorphine waiver training in Oregon . Substance Abuse 43:1, pages 825-833.
Read now
Read now
Jake Monaghan & Brandon del Pozo. (2022) E-Cigarettes, the FDA’s Strategic Orientation, and Lessons from the Opioid Crisis. The American Journal of Bioethics 22:10, pages 23-25.
Read now
Read now
Florence Vorspan, Peter Hjelmström, Nicolas Simon, Amine Benyamina, Alain Dervaux, Georges Brousse, Thierry Jamain, Margaux Kosim & Benjamin Rolland. (2019) What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine. Expert Opinion on Drug Delivery 16:9, pages 907-914.
Read now
Read now
Suprit Parida, Kathleen M. Carroll, Ismene L. Petrakis & Mehmet Sofuoglu. (2019) Buprenorphine treatment for opioid use disorder: recent progress. Expert Review of Clinical Pharmacology 12:8, pages 791-803.
Read now
Read now
Burak Kulaksızoğlu, Hüseyin Kara, Berkan Bodur & Murat Kuloğlu. (2018) Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report. Neuropsychiatric Disease and Treatment 14, pages 3033-3035.
Read now
Read now
Edward V. Nunes. (2018) Buprenorphine in the real world: coming to terms with misuse and diversion. The American Journal of Drug and Alcohol Abuse 44:6, pages 576-577.
Read now
Read now
Michael Soyka. (2017) Treatment of opioid dependence with buprenorphine: current update. Dialogues in Clinical Neuroscience 19:3, pages 299-308.
Read now
Read now
Maciej Gasior, Mary Bond & Richard Malamut. (2016) Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations. Postgraduate Medicine 128:1, pages 85-96.
Read now
Read now
Annette Dale-Perera, Farrukh Alam & Peter Barker. (2015) Opioid-dependence treatment in the era of recovery: insights from a UK survey of physicians, patients and out-of-treatment opioid users. Journal of Substance Use 20:5, pages 354-362.
Read now
Read now
Robert P. Schwartz, Sharon M. Kelly, Jan Gryczynski, Shannon Gwin Mitchell, Kevin E. O'Grady & Jerome H. Jaffe. (2015) Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research. Journal of Addictive Diseases 34:2-3, pages 151-161.
Read now
Read now
Björn Johnson & Torkel Richert. (2015) Diversion of Methadone and Buprenorphine from Opioid Substitution Treatment: Patients who Regularly Sell or Share Their Medication. Journal of Addictive Diseases 34:1, pages 1-17.
Read now
Read now
Sofie Mauger, Ronald Fraser & Kathryn Gill. (2014) Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence. Neuropsychiatric Disease and Treatment 10, pages 587-598.
Read now
Read now
Xiaofan Li, Daryl Shorter & Thomas R Kosten. (2014) Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies. Expert Opinion on Pharmacotherapy 15:15, pages 2263-2275.
Read now
Read now
Verena E. Metz, Laura Brandt, Annemarie Unger & Gabriele Fischer. (2014) Substance Abuse/Dependence Treatment: A European Perspective. Substance Abuse 35:3, pages 309-320.
Read now
Read now
Sharon Stancliff, Herman Joseph, Chunki Fong, Terry Furst, SandraD. Comer & Perrine Roux. (2012) Opioid Maintenance Treatment as a Harm Reduction Tool for Opioid-Dependent Individuals in New York City: The Need to Expand Access to Buprenorphine/Naloxone in Marginalized Populations. Journal of Addictive Diseases 31:3, pages 278-287.
Read now
Read now
Andrew Smirnov & Robert Kemp. (2012) Use and Misuse of Opioid Replacement Therapies: A Queensland Study. Substance Use & Misuse 47:1, pages 78-85.
Read now
Read now
Ayman Fareed, Sreedevi Vayalapalli, Jennifer Casarella & Karen Drexler. (2012) Effect of Buprenorphine Dose on Treatment Outcome. Journal of Addictive Diseases 31:1, pages 8-18.
Read now
Read now
Albert
Stuart Reece. (2010) Favorable Mortality Profile of Naltrexone Implants for Opiate Addiction. Journal of Addictive Diseases 29:1, pages 30-50.
Read now
Read now
Shannon Gwin Mitchell, Sharon M. Kelly, Barry S. Brown, Heather Schacht Reisinger, James A. Peterson, Adrienne Ruhf, Michael H. Agar, Kevin E. O'Grady & Robert P. Schwartz. (2009) Uses of Diverted Methadone and Buprenorphine by Opioid-Addicted Individuals in Baltimore, Maryland. American Journal on Addictions 18:5, pages 346-355.
Read now
Read now
Walter Ling. (2009) Buprenorphine for opioid dependence. Expert Review of Neurotherapeutics 9:5, pages 609-616.
Read now
Read now
R. Douglas Bruce, Sumathi Govindasamy, Laurie Sylla, Adeeba Kamarulzaman & Frederick L. Altice. (2009) Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market. The American Journal of Drug and Alcohol Abuse 35:2, pages 68-72.
Read now
Read now
Estelle Lavie, Mélina Fatséas, Jean-Pierre Daulouède, Cécile Denis, Jacques Dubernet, Laurent Cattan & Marc Auriacombe. (2008) Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002. Patient Preference and Adherence 2, pages 369-378.
Read now
Read now
Campbell K. Aitken, Campbell K. Aitken, Peter G. Higgs & Margaret E. Hellard. (2008) Buprenorphine injection in Melbourne, Australia—an update. Drug and Alcohol Review 27:2, pages 197-199.
Read now
Read now
R. Douglas Bruce, Sumathi Govindasamy, Laurie Sylla, Marwan S. Haddad, Adeeba Kamarulzaman & Frederick L. Altice. (2008) Case Series of Buprenorphine Injectors in Kuala Lumpur, Malaysia. The American Journal of Drug and Alcohol Abuse 34:4, pages 511-517.
Read now
Read now
Amy E. Gibson, Amy E. Gibson, Louisa J. Degenhardt, Amy E. Gibson & Louisa J. Degenhardt. (2007) Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records. Drug and Alcohol Review 26:4, pages 405-410.
Read now
Read now
Elizabeth Cho, Helen Dermatis & Marc Galanter. (2006) Buprenorphine for Heroin Addicts. Substance Abuse 27:1-2, pages 1-3.
Read now
Read now
Thomas R Kosten$suffix/text()$suffix/text(). (2005) What Are America's Opportunities for Harm Reduction Strategies in Opiate Dependence?. American Journal on Addictions 14:4, pages 307-310.
Read now
Read now